Such techniques can be automatically applied using implantable cardioverter defibrillators (ICDs) and offer the potential for painless termination of ventricular tachycardia (VT). Reduction in ...

Kestra Medical recently filed a form S-1 to confirm its intent to go public through an initial public offering (IPO).

How are patients with myocardial scar after a myocardial infarction and ventricular tachycardia currently managed? Implantable cardioverter–defibrillators (ICDs) improve survival in patients ...

An automated implantable cardioverter defibrillator (ICD or AICD) is a permanent device in which a lead (wire) inserts into the right ventricle and monitors the heart rhythm. It is implanted ...

Kestra Medical Technologies announced today that it appointed Al Ford as its new chief commercial officer (CCO).

The first cardioverter-defibrillator, invented and developed by Polish-born Israeli-American physician Michel Mirowski, was implanted in a patient at Johns Hopkins Hospital. Since then ...

Cardioverter defibrillators are small battery-powered devices implanted in the chest. They are designed to detect irregular heartbeats and deliver electric shocks to restore the heart’s regular ...